Tech Company Financing Transactions
Secretome Therapeutics Funding Round
On 11/25/2024, Secretome Therapeutics raised $20.4 million in financing from private investors.
Transaction Overview
Company Name
Announced On
11/25/2024
Transaction Type
Venture Equity
Amount
$20,400,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support operations through mid-2026 and fund key initiatives, including: Clinical trials: Launching two Phase 1 trials of STM-01 in HFpEF (heart failure with preserved ejection fraction) and DCM (dilated cardiomyopathy), with data expected in Q3 2025. Manufacturing scale-up: Transitioning STM-01 manufacturing to 3-dimensional bioreactor technology. Pipeline development: Advancing STM-21 and other preclinical programs to address inflammatory conditions. Regulatory engagement: Defining the regulatory pathway for STM-01 in orphan indications. Intellectual property: Submitting patents on new cell and secretome products following the issuance of composition patents for STM-01 and STM-21.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
323 W. Camden Street 600
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
At Secretome Therapeutics, we aim to redefine treatment for life-threatening diseases by leveraging the power of neonatal cardiac progenitor cells (nCPCs). Our mission is to improve lives through innovative science, scalable solutions, and targeted therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vinny Jindal
Browse more venture capital transactions:
Prev: 11/25/2024: Adcendo venture capital transaction
Next: 11/25/2024: Cofactor AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs